A retrospective analysis of National Lung Screening Trial (NLST) exams has shown that most lung cancers that were detected within a year after a negative CT screening exam—some 40 of 44, or 91 percent—were present but overlooked at the screening. 

GE Healthcare’s Life Sciences business has sealed the deal for the exclusive rights from Rapiscan Pharma Solutions to commercialize Rapiscan (Regadenoson), used in the diagnosis of coronary artery disease (CAD), in territories outside the U.S., Canada and Mexico.

Amnis Therapeutics, a biomedical engineering company in Israel, has received approval from the Karolinska Institute, a medical university in Stockholm, Sweden, to use its neuro-thrombectomy device on patients for the first time in a clinical trial.

A new study from the National Institutes of Health (NIH) found a link between slow development in young children and obesity rates of parents.

The most effective way to diagnose a concussion is through a patient's experience, a CT scan or MRI scan, but a new test that records the way the brain processes sounds could potentially aid in helping scientists treat sports-related concussions.

Experts from the University of Pennsylvania advocated for the use of advanced molecular imaging in cancer care, citing its usefulness from diagnosis to treatment in the Journal of the American Medical Association Oncology.

PET/CT can add value to cancer staging and follow-up in pediatric patients. In fact, it may come to play an important role in directing image-guided biopsies of children, according to a study published online Dec. 27 in the American Journal of Roentgenology.

The medical job market is ripe for radiologists specialized in breast imaging, and new rads considering this career path would do well to read “What You Need to Know—A Primer for Radiologists Entering Breast Imaging,” published online Dec. 22 in the Journal of the American College of Radiology.